October 20, 2021 Comments Off on New patent for Exelixis Inc drug CABOMETYX Posted in: Patent Added Annual Drug Patent Expirations for CABOMETYX Cabometyx is a drug marketed by Exelixis Inc and is included in one NDA. It is available from one supplier. There are nine patents…
The post New patent for Exelixis Inc drug CABOMETYX appeared first on DrugP…
October 20, 2021 Comments Off on New patent for Azurity drug EPANED Posted in: Patent Added Annual Drug Patent Expirations for EPANED Epaned is a drug marketed by Azurity and Silvergate Pharms and is included in two NDAs. It is available from one supplier. There are…
The post New patent for Azurity drug EPANED appeared first on DrugPatentWatc…
